Opendata, web and dolomites

CROWDASSAY SIGNED

Folding Pathways of DNA G-quadruplexes in Crowding Conditions, and Implications for Mass Spectrometry-based Ligand Screening Assays

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "CROWDASSAY" data sheet

The following table provides information about the project.

Coordinator
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE 

Organization address
address: RUE DE TOLBIAC 101
city: PARIS
postcode: 75654
website: www.inserm.fr

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Total cost 173˙076 €
 EC max contribution 173˙076 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2017
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2018
 Duration (year-month-day) from 2018-06-01   to  2020-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE FR (PARIS) coordinator 173˙076.00

Map

 Project objective

Nucleic acids come in many forms aside from the Watson-Crick duplex. For example, guanine-rich DNA strands can form G-quadruplex structures, which have become attractive targets for small molecule ligands. It is now proven that G-quadruplexes can form in cells. Today most biophysical and structural studies on G-quadruplex folding are carried out in dilute aqueous solutions, but recent works suggest that the folding of some G-quadruplexes may differ in a crowded environment such as the cell environment. In the same way, most in vitro ligand binding assays are today carried out in dilute aqueous solutions. The aim of the project is to assess whether and how the folding pathways of G-quadruplexes differs in dilute and crowded conditions, and whether the community should revise the experimental design of ligand screening assays. We will focus on mass spectrometry-based assays, which have the unique advantage to give a direct read-out of ligand binding stoichiometry, quantity, and the variety of structural ensembles hiding behind the free and bound nucleic acid. The research program involves (1) developing mass spectrometry in more “native” conditions in the sense that we will add co-solutes to mimic cellular crowding, (2) comparing the G-quadruplex folding pathways in dilute and crowded conditions, by combining for the first time mass spectrometry, nuclear magnetic resonance, and single-molecule FRET (Förster resonance energy transfer), and (3) evaluating the impact of crowding on both traditional melting assays and mass spectrometry-based ligand screening assays. Our project will contribute to unveil fundamental principles of nucleic acid folding. It will also foster collaboration between three European institutes specialized in complementary biophysical and structural approaches to study G-quadruplexes. Finally, our project will also contribute to society by improving analytical approaches that are highly relevant to pharmacology.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CROWDASSAY" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CROWDASSAY" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

MIGPSC (2018)

Shaping the European Migration Policy: the role of the security industry

Read More  

TIPTOP (2019)

Tensoring Positive Maps on Operator Structures

Read More  

NPsVLCD (2019)

Natural Product-Inspired Therapies for Leishmaniasis and Chagas Disease

Read More